Repligen (RGEN)
(Delayed Data from NSDQ)
$183.92 USD
-0.83 (-0.45%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $183.40 -0.52 (-0.28%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum D VGM
Company Summary
Waltham, MA-based Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies.
Repligen earns revenues from the sale of several products, which can be categorized mainly under four segments — Filtration, Chromatography, Process Analytics and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products and SIUS filtration ...
Company Summary
Waltham, MA-based Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies.
Repligen earns revenues from the sale of several products, which can be categorized mainly under four segments — Filtration, Chromatography, Process Analytics and Protein products. The chromatography products include OPUS and OPUS PD chromatography columns, chromatography resins and ELISA test kits. Filtration products consist of XCell Alternating Tangential Flow (ATF) Systems and consumables, KrosFlo filtration products and SIUS filtration products. Protein products comprise the Protein A ligands and cell culture growth factors.
The company acquired privately held bioprocess analytics company C Technologies for $240 million in a cash-and-stock deal, in 2019. The acquisition marked Repligen’s entry into process analytics and added its fourth franchise by the name Process Analytics products.
Repligen has made a few promising acquisitions in the past couple of years to diversify its business or boost its core competencies. In 2020, Repligen acquired New York-based Engineered Molding Technology and Non-Metallic Solutions. In December 2020, it acquired privately-held ARTeSYN Biosolutions for approximately $200 million. In 2021, Repligen acquired Polymem, followed by Avitide and Bio-Flex Solutions.
The company reported total revenues of $801.5 million in 2022, up 20% year over year.
General Information
Repligen Corporation
41 SEYON STREET BUILDING 1 SUITE 100
WALTHAM, MA 02453
Phone: 781-250-0111
Fax: 781-250-0115
Email: investors@repligen.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 12/31/2023 |
Exp Earnings Date | 5/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.29 |
Current Year EPS Consensus Estimate | 1.46 |
Estimated Long-Term EPS Growth Rate | 21.00 |
Exp Earnings Date | 5/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 184.75 |
52 Week High | 211.13 |
52 Week Low | 110.45 |
Beta | 1.03 |
20 Day Moving Average | 391,947.16 |
Target Price Consensus | 200.18 |
4 Week | -5.19 |
12 Week | 7.20 |
YTD | 2.29 |
4 Week | -8.04 |
12 Week | -4.34 |
YTD | -6.62 |
Shares Outstanding (millions) | 55.77 |
Market Capitalization (millions) | 10,257.42 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 126.36 |
Trailing 12 Months | 106.31 |
PEG Ratio | 6.02 |
vs. Previous Year | -51.47% |
vs. Previous Quarter | 43.48% |
vs. Previous Year | -16.61% |
vs. Previous Quarter | 10.31% |
Price/Book | 5.21 |
Price/Cash Flow | 60.78 |
Price / Sales | 16.06 |
12/31/23 | 5.00 |
9/30/23 | 6.08 |
6/30/23 | 7.83 |
12/31/23 | 3.78 |
9/30/23 | 4.69 |
6/30/23 | 5.95 |
12/31/23 | 7.02 |
9/30/23 | 2.69 |
6/30/23 | 2.67 |
12/31/23 | 5.75 |
9/30/23 | 2.11 |
6/30/23 | 2.03 |
12/31/23 | 15.40 |
9/30/23 | 17.73 |
6/30/23 | 20.56 |
12/31/23 | 6.51 |
9/30/23 | 17.29 |
6/30/23 | 18.92 |
12/31/23 | 10.04 |
9/30/23 | 18.79 |
6/30/23 | 22.17 |
12/31/23 | 35.31 |
9/30/23 | 35.62 |
6/30/23 | 35.40 |
12/31/23 | 1.57 |
9/30/23 | 1.52 |
6/30/23 | 1.40 |
12/31/23 | 0.26 |
9/30/23 | 0.00 |
6/30/23 | 0.00 |
12/31/23 | 20.56 |
9/30/23 | 0.00 |
6/30/23 | 0.00 |